DOCSLIB.ORG

Infection Current Awareness Update – 17/08/2020

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Infection Current Awareness Update – 17/08/2020 Infection Current Awareness Update – 17/08/2020 Welcome to the weekly Infection Current Awareness Update (ICAU), produced by PHE Knowledge and Library Services. The purpose of this update is to provide you with the latest, best evidence about infection, to help you make informed decisions. Please note: PHE KLS has set up a separate COVID-19 Daily Alert of latest research. If you would like to receive this, please email [email protected]. In addition to this, a page of resources about the coronavirus is available here. If you have any queries, please contact us at [email protected], and if you would like to request a literature search, please use the Knowledge and Library Services Enquiries Portal (PHE staff only). Please note that not all the articles and resources referred to in this alert are freely available. Some articles may require an Athens username and password, and for PHE and NHS staff, these can be obtained here. If you do not work for PHE or the NHS, you may want to approach your local health library service to discuss how you may have access to library services. COVID-19 related research • COVID-19 infection - 1 Infection-related guidance • Guidelines: PubMed search for HIV and British HIV Association - 1 • British Society for Antimicrobial Chemotherapy - 1 • European Centre for Disease Prevention and Control - 2 • Infectious Diseases Society of America - 2 Infection-related journals • American Journal of Infection Control - 16 • American Journal of Medical Quality: Current issue - 1 • Clinical Infectious Diseases - Advance Access - 47 • Clinical Infectious Diseases - Current Issue - 7 • Clinical Microbiology and Infection - 6 • Current Opinion in Microbiology - 3 • Current Opinion in Virology - 1 • Diagnostic Microbiology and Infectious Disease - 12 • Emerging Infectious Diseases Journal - ahead of print - 6 • European Journal of Clinical Microbiology & Infectious Diseases - 10 • Eurosurveillance latest updates - 5 • Hepatology - 3 • Infection - 4 • International Journal of Medical Microbiology - 1 • Infection Control & Hospital Epidemiology - FirstView Article - 9 • International Journal of Infectious Diseases - 30 • Journal of Clinical Virology - 9 • Journal of Hospital Infection - 10 • Journal of Infection - 14 • Journal of Microbiology, Immunology and Infection - 10 • Lancet - 2 • Morbidity and Mortality Weekly Report (MMWR) - 12 • Nature Reviews Microbiology - Current Issue - 2 • New England Journal of Medicine - Current Issue - 3 • Scandinavian Journal of Infectious Diseases: Table of Contents - 1 NIS Affiliation • PubMed: NIS affiliation - 7 COVID-19 related research COVID-19 infection [Correspondence] COVID-19 combination prevention requires attention to structural drivers 14 Aug 2020 Richard Horton draws parallels between the colliding pandemics of COVID-19 and HIV, observing that both “exploit and accentuate inequalities”.1 He and others2 advocate that responses to COVID- 19 learn from HIV combination prevention approaches [back to top] Infection-related guidance Guidelines: PubMed search for HIV and British HIV Association [Some learned lessons (or not so much) from COVID-19]. 13 Aug 2020 Related Articles [Some learned lessons (or not so much) from COVID-19]. J Healthc Qual Res. 2020 Jul - Aug;35(4):207-208 Authors: Natal C PMID: 32646773 [PubMed - indexed for MEDLINE] [back to top] British Society for Antimicrobial Chemotherapy BSAC meets UNICEF: it’s time to protect our children against the biggest threat to their lives – superbugs 11 Aug 2020 The post BSAC meets UNICEF: it’s time to protect our children against the biggest threat to their lives – superbugs appeared first on British Society for Antimicrobial Chemotherapy. [back to top] European Centre for Disease Prevention and Control COVID -19 clusters and outbreaks in occupational settings in the EU/EEA and the UK 11 Aug 2020 The aim of this document is to describe COVID-19 clusters and outbreaks in the EU/EEA and the UK linked to occupational settings, including healthcare and non-healthcare settings, and to identify possible factors contributing to transmission in these settings. Objectives for COVID-19 testing in school settings 10 Aug 2020 further transmission.To identify infection in students and staff at high risk of developing severe disease [back to top] Infectious Diseases Society of America We published in Clinical Infectious Diseases (@IDSAInfo) an analysis looking at completion, safety, and efficacy of #rifampin vs. #isoniazid for treatment of #tuberculosis infection in participants from two #RCTs with health conditions (incl. #HIV). doi.org/10.1093/cid/ci… (1/5) 13 Aug 2020 infection in participants from two #RCTs with health conditions (incl. #HIV). https://t.co/lyOGAOgfON (1/5)" "There are studies to suggest... young children are less susceptible to serious infection, but more importantly, they transmit less." @IDSAInfo and @JHSPH_CHS experts tell us what we need to know about #Covid19 and kids. pic.twitter.com/loKhw1IjOS 10 Aug 2020 susceptible to serious infection, but more importantly, they transmit less."@IDSAInfo and @JHSPH_CHS experts [back to top] Infection-related journals American Journal of Infection Control Clostridioides difficile Infections in Alberta: The Validity of Administrative Data using ICD-10 Diagnostic codes for CDI Surveillance versus Clinical Infection Surveillance 15 Aug 2020 Clostridioides difficile (C. difficile) is an anaerobic, spore-forming bacterium that is responsible for various C. difficile infections (CDI) including infectious diarrhea, pseudomembranous colitis, and toxic megacolon, which can lead to bowel perforation, sepsis and death.1, 2 C Impact of the Blue-Carba Rapid Test for Carbapenemase Detection on Turnaround Time for an Early Therapy Against Pseudomonas aeruginosa 15 Aug 2020 To determine the turnaround time from a blue-carba result until a final microbiological report (bacterial identification plus antimicrobial susceptibility profile) and to infer the impact of an early therapeutic intervention based on the blue-carba results. Improving antimicrobial stewardship in an Acute Medical Unit (AMU) during patient discharge following introduction of an Antimicrobial Information Card 15 Aug 2020 Despite government incentives to reduce 30-day hospital readmissions, emergency readmissions are increasing1. Infection-related conditions remains the most common reason for both initial admission and readmission within 30 days of initial discharge, with antibiotics commonly prescribed to treat infections2 Four moments for healthcare facility visitor hand hygiene 15 Aug 2020 The coronavirus disease 2019 (COVID-19) pandemic has highlighted the concern that visitors to healthcare facilities are at risk to acquire or transmit pathogenic microorganisms.1 In an outbreak of COVID-19 in a long-term care facility, 16 visitors were diagnosed with infection, and half required hospitalization Impact of Extended Use and Decontamination with Vaporized Hydrogen Peroxide on N95 Respirator Fit 14 Aug 2020 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging pathogen that is spreading worldwide. It is primarily transmitted by respiratory droplets and by direct and indirect contact; however, airborne transmission can also occur in the context of aerosol generating medical procedures (AGMPs), necessitating the usage of N95 respirators for protection of healthcare workers (HCWs) Environmental Cleaning and Disinfection of Hospital Rooms: A Nationwide Survey 13 Aug 2020 Environmental surfaces in the hospital have long been identified as a reservoir for pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and Clostridiodes difficile Outbreak Investigation of COVID-19 in Hospital Food Service Workers 13 Aug 2020 SARS-CoV-2, the virus that causes COVID-19, is primarily spread person-to-person via contact with infected respiratory droplets.1 It is estimated that an individual may be infectious prior to becoming symptomatic.2 Areas with crowded work spaces and poor ventilation may be associated with higher transmission.3 Implementation and Process of a COVID-19 Contact Tracing Initiative: Leveraging Health Professional Students to Extend the Workforce During a Pandemic 13 Aug 2020 In the context of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the pandemic of the coronavirus disease-2019 (COVID-19) in the United States (US), the Centers for Disease Control and Prevention (CDC) has recommended the identification of symptomatic and asymptomatic infected individuals can contribute to control of the pandemic Management of Gastrointestinal Endoscopy Unit during Post Covid-19 Endemic Outbreak: A Report from Wuhan Epicenter 13 Aug 2020 The COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) and causing a global public health emergency. During the outbreak, Wuhan was the first reported and hardest-hit city. With the dramatic drop in number of confirmed cases and subsequent ending of Wuhan lock down, asymptomatic carriers and patients in their recovery period still pose an increased risk Face touching in the time of COVID-19 in Shiraz, Iran 12 Aug 2020 SARS-CoV-2 has spread rapidly affecting over 10.4 million global citizens and the easy of spread has been demonstrated by the high burden across the globe.1 Two characteristics of the virus that offers an understanding of the effectiveness for transmission are direct transmission during the pre- symptomatic and symptomatic period and
Load more

Recommended publications
  • Medical Directors Arup Medical Directors and Consulting Faculty | 2015
    MEDICAL DIRECTORS ARUP MEDICAL DIRECTORS AND CONSULTING FACULTY | 2015 MAY 2015 www.aruplab.com Information in this brochure is current as of May 2015. All content is subject to change. Please contact ARUP Client Services at (800) 522-2787 with any questions or concerns. ARUP LABORATORIES ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology. Located in Salt Lake City, Utah, ARUP offers in excess of 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. Rather than competing with its clients for physician office business, ARUP chooses instead to support clients’ existing test menus by offering complex and unique tests, with accompanying consultative support, to enhance their abilities to provide local and regional laboratory services. ARUP’s clients include many of the nation’s university teaching hospitals and children’s hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®. Since its formation in 1984 by the Department of Pathology at the University of Utah, ARUP has founded its reputation on reliable and consistent laboratory testing and service. This simple strategy contributes significantly to client satisfaction. When ARUP conducts surveys, clients regularly rate ARUP highly and respond that they would recommend ARUP to others. As the most responsive source of quality information and knowledge, ARUP strives to be the reference laboratory of choice for community healthcare systems.
    [Show full text]
  • Job Posting Clinical Microbiology Final
    The Department of Pathology & Cell Biology at Columbia University Irving Medical Center (CUIMC) is recruiting for an MD, MD/PhD, or PhD academic clinical microbiologist of any rank to join our faculty as a Medical Director of the NewYork-Presbyterian/CUIMC Clinical Microbiology Laboratory. Applicants should have an established track record of accomplishment within the field of clinical microbiology and a demonstrated ability to lead an experienced group of laboratory technologists, supervisors, and staff. In addition to strong clinical and technical skills, particular emphasis is placed on candidates with a demonstrated record of collegiality and inter-departmental collaboration. Applicants must have completed a fellowship in clinical microbiology and be board-certified/board-eligible in Medical and Public Health Microbiology through the American Board of Medical Microbiology (ABMM) or board-certified/board- eligible in Clinical Pathology with subspecialty certification in Medical Microbiology through the American Board of Pathology (ABP). The applicant must also be able to satify clinical licensing requirements to serve as a Laboratory Director in New York State. The successful applicant will help oversee diagnostic testing in the areas of Bacteriology, Virology, Mycobacteriology, Mycology, and Parasitology. The position also includes responsibilities for teaching of pathology residents, medical students, infectious diseases fellows, and technical staff. Applicants must be currently involved in ongoing research with a track record of publications in the field. The position offers a competitive salary commensurate with training and experience, and an appointment to the faculty of the Columbia University Vagelos College of Physicians & Surgeons. The Clinical Microbiology Laboratory at NewYork-Presbyterian/CUIMC is located in the Washington Heights neighborhood of New York City, offering unparalleled opportunities to work and live in a thriving, diverse, metropolitan environment with access to world-class cultural institutions, restaurants, and entertainment.
    [Show full text]
  • DUKE UNIVERSITY School of Medicine Pathologists' Assistant
    DUKE UNIVERSITY School of Medicine Pathologists’ Assistant Program Department of Pathology Academic Programs The Department of Pathology at Duke University offers a wide array of training programs to fit individual requirements and goals. The Residency Training program is an ACGME approved program and is available as an Anatomic Pathology/Clinical Pathology combined program, a shorter Anatomic Pathology only program, or an Anatomic Pathology/Neuropathology program. Subspecialty fellowships in Cytopathology, Dermatopathology, Hematopathology, Medical Microbiology, and Neuropathology are also ACGME approved. These programs provide the highest quality of graduate medical education by drawing on the depth and breadth of faculty expertise in the Department in all aspects of anatomic and clinical pathology and the availability of a wide variety of often complex clinical cases seen at Duke University Health System. For medical students interested in a career in Pathology pre-doctoral fellowships, internships and externships are available. Research Training in Experimental pathology can be obtained through Pre- and postdoctoral fellowships of one to five years. All pre-doctoral fellows are candidates for the Ph.D. degree in pathology. The Ph.D. is optional in postdoctoral programs, which provide didactic and research training in various aspects of modern experimental pathology. A two year NAACLS accredited Pathologists’ Assistant Program leads to a Master of Health Science degree, certifies graduates to sit for the ASCP Board of Certification examination, and leads to exciting career opportunities in a variety of anatomic pathology laboratory settings. Pathologists’ assistants are analogous to physician assistants, but with highly specialized training in autopsy and surgical pathology. This profession was pioneered in the Duke Department of Pathology 50 years ago, and is one of only twelve such programs in existence today.
    [Show full text]
  • Medical Microbiology and Infectious Diseases 22% Specialists in 2017 = 11%3
    Medical Microbiology & Infectious Diseases Profile Updated December 2019 1 Table of Contents Slide . General Information 3-5 . Total number & number/100,000 population by province, 2019 6 . Number/100,000 population, 1995-2019 7 . Number by gender & year, 1995-2019 8 . Percentage by gender & age, 2019 9 . Number by gender & age, 2019 10 . Percentage by main work setting, 2019 11 . Percentage by practice organization, 2017 12 . Hours worked per week (excluding on-call), 2019 13 . On-call duty hours per month, 2019 14 . Percentage by remuneration method 15 . Professional & work-life balance satisfaction, 2019 16 . Number of retirees during the three year period of 2016-2018 17 . Employment situation, 2017 18 . Links to additional resources 19 2 General information Microbiology and infectious diseases focuses on the diagnosis and treatment of infectious diseases; thus, it is concerned with human illness due to micro-organisms. Since such disease can affect any and all organs and systems, this specialist must be prepared to deal with any region of the body. The specialty of Medical Microbiology and Infectious Disease consists primarily of four major spheres of activity: 1. the provision of clinical consultations on the investigation, diagnosis and treatment of patients suffering from infectious diseases; 2. the establishment and direction of infection control programs across the continuum of care; 3. public health and communicable disease prevention and epidemiology; 4. the scientific and administrative direction of a diagnostic microbiology laboratory. Source: Pathway evaluation program 3 General information Once you’ve completed medical school, it takes an additional 5 years of Royal College-approved residency training to become certified in medical microbiology and infectious disease.
    [Show full text]
  • 2016 AAAAI Honorary Award Recipients Outstanding Volunteer Clinical Faculty Award
    2016 AAAAI Honorary Award Recipients Outstanding Volunteer Clinical Faculty Award Presented in recognition of service to the allergy/immunology training program at the David Geffen School of Medicine at UCLA as a teacher and mentor. Roger H. Kobayashi, MD, FAAAAI Clinical Professor of Pediatrics, UCLA School of Medicine Physician, Allergy, Asthma & Immunology Associates, P.C. Roger H. Kobayashi is in private practice in Omaha, Nebraska and has also served, for the past 25 years, on the Volunteer Faculty at the University of California, Los Angeles (UCLA), where he is a Clinical Professor. He previously served on the full time faculty at the University of Nebraska (Director of Immunology/Allergy with tenured rank of Associate Professor of Pediatrics & Medical Microbiology) and UCLA School of Medicine (Director, Pediatric Allergy Clinic). Dr. Kobayashi was born and raised in Honolulu, Hawaii and received his BA in Economics and MD from the University of Nebraska as well as an MS in cardiovascular physiology from the University of Hawaii-Manoa. He received his residency and fellowship training at the University of Southern California and UCLA respectively. Of the 80 papers he has published, most have focused on asthma and recurrent infections in the pediatric population. He has been visiting professor at a number of U.S. medical schools as well as the Universities of Hanoi, Hue and the Military Medical School in Hanoi, and an invited lecturer in Europe, Asia, the Middle East and Central America. He has testified before Congress, as well as the State Legislatures of Hawaii and Nebraska on health access issues. He is an Expert Consultant for the Immune Deficiency Foundation and is a recipient of their Physician Volunteer Award and was founding member and first President of the Nebraska Allergy Society.
    [Show full text]
  • 2019-General-Pathology-Faq.Pdf
    FREQUENTLY ASKED QUESTIONS – 2019 Program: GENERAL PATHOLOGY Specialty/Field Questions: 1. a) What are some strengths about your specialty? What draws and keeps people in your specialty? • The opportunity to understand the nature of disease in an in-depth way that isn’t achieved in any other specialty. You get to practice scientific diagnostic medicine over a broad range of subjects and you have a fair degree of control over your schedule. You are very much a part of the team taking care of the patient (it just isn’t as obvious!), and this is becoming even more apparent in the era of precision medicine. • Although there is limited direct contact with patients, there is a great deal of contact with a variety of clinicians outside the laboratory as well as with physician, PhD, and technical staff colleagues within the laboratory. We get satisfaction from the interactions we have with others, and knowing that we are helping a clinician take the next step in diagnosing or treating a patient. The stereotypical image of the hermit- like pathologist who stays in their office and never talks to anyone is rapidly disappearing in today’s pathology practice. b) What are some common complaints about your specialty? • There is limited direct clinical contact – you’ll never have an office full of patients who regard you as their doctor and most pathologists have a hospital-based practice which can limit professional autonomy. • You often have to sit/stand at a microscope and/or computer a lot, so sometimes you need to get creative about staying active during the day.
    [Show full text]
  • Medical Bacteriology
    LECTURE NOTES Degree and Diploma Programs For Environmental Health Students Medical Bacteriology Abilo Tadesse, Meseret Alem University of Gondar In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education September 2006 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2006 by Abilo Tadesse, Meseret Alem All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. PREFACE Text book on Medical Bacteriology for Medical Laboratory Technology students are not available as need, so this lecture note will alleviate the acute shortage of text books and reference materials on medical bacteriology.
    [Show full text]
  • History of the Department of Microbiology 1868 – 2009
    June 2015 HISTORY OF THE DEPARTMENT OF MICROBIOLOGY 1868 – 2009 University of Illinois at Urbana-Champaign 1 A HISTORY OF THE DEPARTMENT OF MICROBIOLOGY 1868 – 2009 This 141 year history of the Department of Microbiology includes an article (Chapter 1), written and published in 1959 by the Department, which covers the period 1868 to 1959. I joined the Department in 1953, and my recounting of the Department’s history includes personal observations as well as anecdotes told to me by H. O. Halvorson and others. Later I realized what a unique experience it had been to join a first-class department, and I resolved to play a role in maintaining its research stature. Ralph Wolfe 2 Department of Microbiology History of the Headship: 1950 – 1959 Halvor Halvorson 1960 – 1963 Kim Atwood 1963 – 1972 Leon Campbell 1972 – 1982 Ralph DeMoss 1982 – 1987 Samuel Kaplan 1987 – 1990 Jordan Konisky 1990 – 1991 Ralph Wolfe (Acting Head) 1991 – 1997 Charles Miller 1997 – 2002 John Cronan 2003 – 2004 Jeffrey Gardner (Acting Head) 2005 – Present John Cronan 3 Organization of the History of the Department In Chapters 2 to 6 the data are divided into Academic Decades, each containing the following sections: Section I, an overview of the decade; Section II, some events for each year of the decade; Section III, a summary of the research interests, honors received, publications, and invited off-campus lectures or seminars for each faculty member. These data have been obtained from the annual reports of the faculty submitted to the departmental secretary. 4 CHAPTER 1 1868 – 1959 During this time period the name of the Department was Department of Bacteriology (Anecdotes by Ralph Wolfe) A SHORT HISTORY OF THE DEPARTMENT OF BACTERIOLOGY H.
    [Show full text]
  • 2021 Anatomic & Clinical Pathology
    BEAUMONT LABORATORY 2021 ANATOMIC & CLINICAL PATHOLOGY Physician Biographies Expertise BEAUMONT LABORATORY • 800-551-0488 BEAUMONT LABORATORY ANATOMIC & CLINICAL PATHOLOGY • PHYSICIAN BIOGRAPHIES Peter Millward, M.D. Mitual Amin, M.D. Chief of Clinical Pathology, Beaumont Health Interim Chair, Pathology and Laboratory Medicine, Interim Chief of Pathology Service Line, Beaumont Health Royal Oak Interim Physician Executive, Beaumont Medical Group Interim Chair, Department of Pathology and Laboratory Medicine, Oakland University William Beaumont School Interim System Medical Director, Beaumont Laboratory of Medicine Outreach Services Board certification Associate Medical Director, Blood Bank and • Anatomic and Clinical Pathology, Transfusion Medicine, Beaumont Health American Board of Pathology Board certification Additional fellowship training • Anatomic and Clinical Pathology, • Surgical Pathology American Board of Pathology Special interests Subspecialty board certification • Breast Pathology, Genitourinary Pathology, • Blood Banking and Transfusion Medicine, Gastrointestinal Pathology American Board of Pathology Lubna Alattia, M.D. Kurt D. Bernacki, M.D. Cytopathologist and Surgical Pathologist, Trenton System Medical Director, Surgical Pathology Board certification Beaumont Health • Anatomic and Clinical Pathology, Chief, Pathology Laboratory, West Bloomfield American Board of Pathology Breast Care Center Subspecialty board certification Diagnostic Lead, Pulmonary Tumor Pathology • Cytopathology, American Board of Pathology Diagnostic
    [Show full text]
  • Editorial Note on Medical Microbiology & Diagnosis – Clinical
    Manuscript no.- JMMD-2021-5 Article type- Editorial Received date- 20-01-2021 Accepted- 20-01-2021 Publish date-23-01-2021 Editorial Note on Medical Microbiology & Diagnosis – Clinical Microbial Pathology Tirpude RJ Defence Institute of Physiology and Allied Sciences Address for Correspondence: Tirpude RJ, Defence Institute of Physiology and Allied Sciences, Delhi - 110054, India. Tel-9869217101, E-mail: [email protected] Editorial Clinical pathology is concerned with the diagnosis of disease based on laboratory analysis of body fluids like urine and blood. It deals with the tools of microbiology like macroscopic, microscopic, analyzers and cultures. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports. The pathogenesis of a disease is the biological mechanism that leads to the diseased state. It also describes the origin and development of the disease, and whether it is acute, chronic, or recurrent. Medical microbiology involves the identification of microorganisms for the diagnosis of infectious diseases and the assessment of likely response to specific therapeutic interventions. Major categories of organisms include bacteria, mycobacteria, fungi, viruses, and parasites. Microbiological methods combined with clinical symptoms, additional laboratory tests, and imaging techniques are used in combination to distinguish a true disease- associated infection from colonization with normal flora or other conditions, such as malignancies, inflammatory disorders, or autoimmune disorders, all of which have unique therapies and prognoses for the patient. Laboratories combine the use of traditional microscopy and culture methods, with a rapidly evolving set of molecular and proteomic techniques.
    [Show full text]
  • About Mayo Clinic
    Division of Clinical Microbiology Mayo Clinic, Rochester, Minnesota, USA ESCMID program contacts: Bobbi S. Pritt, MD, MSc [email protected] Robin Patel, MD, [email protected] (On-site Contact) About Mayo Clinic Providing the best • Tertiary care center care to every patient every day • First and largest multidisciplinary, through integrated integrated nonprofit medical group practice clinical practice, in the world education and research • Ranked #1 on the 2015-2018 U.S. News & World Report List of “Best Hospitals” in the USA • Over $500 million/year spent on research About Clinical Microbiology At Mayo Clinic • Founded in 1911 Who We Are: Laboratory Directors/Faculty/Consultants • Internationally renowned reference and development laboratory that supports the clinical practice at Mayo Clinic • >3 million laboratory tests performed annually • 7 Microbiology Specialty Laboratories: Robin Patel, MD Bobbi Pritt, MD Elitza Theel, PhD Joseph Yao, MD Nancy Wengenack, PhD Matthew Binnicker, Audrey Schuetz, MD Division Chair, Parasitology Director Infectious Diseases Hepatitis/HIV Mycology/ PhD Virology Director Bacteriology Co- • Initial Processing Bacteriology Co- Serology Director Director Mycobacteriology Director, Initial Director Director Processing Director • Bacteriology • Mycology • Mycobacteriology Education in Clinical Microbiology • Virology • Hepatitis/HIV Opportunities for Observers: • Parasitology • Rotation on clinical benches • Infectious Diseases Serology • Completion of unknown sets and examinations/quizzes • Exposure to cutting-edge research and new test development • Over 250 staff including: • 7 MD/PhD Laboratory Directors Rounds and Seminars (selected): • 3 Clinical Microbiology Fellows • Microbiology Teaching Rounds twice/week • 8 Research/Development Specialists • Book Review Sessions thrice/week • 9 Education Specialists • Journal Club once/month • Accreditation: • On-call Conference twice/month • U.S.
    [Show full text]
  • Medical Microbiology and Immunology 1
    Medical Microbiology and Immunology 1 MEDICAL MICROBIOLOGY AND Doctor of Philosophy (Ph.D.) Program The objective of the program is to prepare highly qualified students for IMMUNOLOGY a broad range of possible careers in research and teaching in medical microbiology and immunology and related health science fields. Study Program Director: Patrick C. Swanson, Ph.D. for the Ph.D. degree emphasizes independence in scientific pursuit, Program Office: Criss II, Room 529 with a particular emphasis on research. Course work and dissertation research are designed to bring the student to a high-level of competence Graduate Study in Medical Microbiology in microbiology and immunology with particular expertise in the area chosen for dissertation research. You will be expected to demonstrate and Immunology a high capacity for original and independent thought, and apply this Within the context of Creighton as a Jesuit, Catholic University, the creativity, educational background, and knowledge of the scientific Graduate School provides value-centered education for students to method to dissertation research. develop mastery of their chosen field of study. The Medical Microbiology and Immunology programs offer an environment ideal for fostering Master of Science (M.S.) Program critical judgment, scholarly initiative, and disciplined inquiry. The objectives of the program include preparation of the student for one or more of the following careers: Program Goals At the completion of this graduate program in Medical Microbiology & 1. teaching of medical microbiology and immunology at the Immunology, students will: undergraduate level, and 2. participation in supervised or team research in universities, industry 1. Demonstrate advanced knowledge in the fields of Medical or government.
    [Show full text]